SJ medical
1 / 5
Carboplatin is a widely utilized chemotherapy agent belonging to the platinum-based antineoplastic drug family. It primarily works by binding to intracellular DNA, forming cross-links that disrupt DNA replication and transcription, ultimately inducing apoptosis in rapidly dividing cancer cells.
Compared to first-generation cisplatin, Carboplatin demonstrates significantly reduced nephrotoxicity and neurotoxicity; however, it more commonly causes myelosuppression. It remains a fundamental component in many oncology chemotherapy regimens due to its improved tolerability.
| Product Name | Carboplatin |
| Appearance | White Powder |
| CAS | 41575-94-4 |
| MF | C6H12N2O4Pt |
| MW | 371.256 |
Broad Efficacy: Demonstrates extensive efficacy in managing ovarian cancer (first-line treatment), non-small cell lung cancer (NSCLC), and head and neck cancers.
Clinical Advantage: Valued for its favorable toxicity profile, causing significantly less renal and ear-related toxicity compared to cisplatin.
Customized Dosing: Typically calculated using the Calvert formula, incorporating the patient's GFR to optimize the therapeutic index.
Our Carboplatin powder maintains a high purity level of ≥99% as determined by HPLC testing.
The product is compliant with GMP, HSE, ISO 9001, USP, and BP standards, ensuring pharmaceutical-grade quality.
It should be stored in a cool, dry place away from direct light. It has a stable shelf life of 2 years when kept under proper conditions.
It is widely used for treating ovarian cancer, non-small cell lung cancer, and head and neck cancers, typically as a core component of combination chemotherapy.
Our current production capacity is approximately 500kg per month to support large-scale pharmaceutical needs.
Dosage is individualized and usually calculated using the Calvert formula based on the patient's glomerular filtration rate (GFR).
